Skip to content

Clinical trials

Phase 3 Lymphoma, Mantle-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 3 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20132
20171
20191
20214
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Recruiting4
Unknown status3
Completed2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines2
Janssen Research & Development, LLC2
Shandong Provincial Hospital2
Acerta Pharma BV1
Beijing InnoCare Pharma Tech Co., Ltd.1
Guangzhou Lupeng Pharmaceutical Company LTD.1
InnoCare Pharma Inc.1
Loxo Oncology, Inc.1
Millennium Pharmaceuticals, Inc.1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell14
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, B-Cell3
Lymphoma, Non-Hodgkin3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Follicular2
Bronchiolitis Obliterans Syndrome1
Burkitt Lymphoma1
Hematologic Diseases1
Lymphoma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.